PDLI - PDL Biopharma Inc
Previous close
2.47
0 0%
Share volume: 0
Last Updated: Wed 30 Dec 2020 06:00:00 AM CET
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$2.47
0.00
0.00%
Summary score
41%
Profitability
51%
Dept financing
33%
Liquidity
75%
Performance
25%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-1.58%
Return on assets
1.01%
Return on sales
59.26%
Return on invested capital
24.33%
Total debt ratio
27.71%
Debt ratio change over timeo
5.96%
Current Ratio
7.71%
Quick Ratio
7.45%
Cash Position Ratio
4.73%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-7.42%
Return on assets
-1.99%
Return on sales
59.38%
Return on invested capital
95.49%
Total debt ratio
19.72%
Debt ratio change over timeo
-9.11%
Current Ratio
10.92%
Quick Ratio
10.43%
Cash Position Ratio
4.34%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-11.88%
Return on assets
-1.96%
Return on sales
-195.43%
Return on invested capital
449.1%
Total debt ratio
19.24%
Debt ratio change over time
-1.41%
Current Ratio
13.68%
Quick Ratio
13.33%
Cash Position Ratio
2.91%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-390.41%
Return on assets
-61.83%
Return on sales
535.43%
Return on invested capital
-684.94%
Total debt ratio
595.86%
Debt ratio change over time
5.96%
Current Ratio
258.23%
Quick Ratio
252.75%
Cash Position Ratio
204.06%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | PDLI | SGEN | NK | SRNG |
---|---|---|---|---|
Return on equity | -1.58% | -4.61% | -11.83% | 0% |
Return on assets | 1.01% | -4.6% | -10.3% | 0% |
Return on sales | 59.26% | -37.29% | 0% | 0% |
Return on invested capital | 24.33% | 265.33% | -27.14% | 0% |
Profitability | 52% | 25% | 0% | 25% |
Total debt ratio | 27.71% | 18.22% | 14.3% | 0% |
Debt ratio change over time | 5.96% | -1.66% | -1.56% | 0% |
Dept financing | 50% | 16% | 13% | 0% |
Current Ratio | 10.92% | 4.65% | 5.1% | 0% |
Quick Ratio | 10.43% | 4.32% | 0% | 0% |
Cash Position Ratio | 4.34% | 0.81% | 2.5% | 0% |
Liquididy | 75% | 31% | 31% | 0% |
Short-term ratios | PDLI | SGEN | NK | SRNG |
---|---|---|---|---|
Return on equity | -7.42% | -3.62% | -13.55% | 0% |
Return on assets | -1.99% | -3.93% | -11.56% | 0% |
Return on sales | 59.38% | -34.27% | 0% | 0% |
Return on invested capital | 95.49% | -9.88% | -24.84% | 0% |
Profitability | 50% | 0% | 0% | 50% |
Total debt ratio | 19.72% | 15.47% | 15.89% | 0% |
Debt ratio change over time | -9.11% | -0.59% | -1.72% | 0% |
Dept financing | 25% | 20% | 20% | 25% |
Current Ratio | 10.92% | 4.65% | 5.1% | 0% |
Quick Ratio | 10.43% | 4.32% | 0% | 0% |
Cash Position Ratio | 4.34% | 0.81% | 2.5% | 0% |
Liquididy | 75% | 26% | 26% | 0% |